Anthera Pharma (ANTH) Prices 60.6M Offering at 66c/Share

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced the pricing of an underwritten public offering of 60,606,061 shares of its common stock, offered at a price of $0.66 per share. The Company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million. The offering is expected to close on or about January 30, 2013, subject to customary closing conditions. In addition, Anthera has granted the underwriters a 30-day option to purchase up to an additional 9,090,909 shares of common stock. The Company intends to use the net proceeds from the offering for general corporate purposes.

Jefferies & Company, Inc. is acting as sole book-running manager in the offering and Leerink Swann LLC is acting as co-manager. Trout Capital LLC has acted as an advisor to the Company.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• MAIA Biotechnology (MAIA) files $150M mixed shelf
• Noodles & Company (NDLS) files $100M mixed shelf